Abbott Laboratories (ABT) Cash from Investing Activities Growth (5y) (2014 - 2026)
Abbott Laboratories (ABT) Cash from Investing Activities Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.54 Bn | 193.94 Bn | 7.27 Bn |
| 2 | Stryker | 129.61 Bn | 126.14 Bn | 4.50 Bn |
| 3 | Medtronic | 120.10 Bn | 110.88 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.52 Bn | 48.27 Bn | 1.35 Bn |
| 6 | Dexcom | 34.69 Bn | 32.75 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.78 Bn | 31.68 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn |
| 9 | Steris | 23.09 Bn | 22.61 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.37 Bn | 18.96 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -20.58% |
| Mar 31, 2026 | -117.04% |
| Dec 31, 2025 | -4.55% |
| Sep 30, 2025 | 0.64% |
| Jun 30, 2025 | 1.23% |
| Mar 31, 2025 | -3.64% |
| Dec 31, 2024 | -12.11% |
| Sep 30, 2024 | -6.58% |
| Jun 30, 2024 | 1.88% |
| Mar 31, 2024 | -1.42% |
| Dec 31, 2023 | -10.69% |
| Sep 30, 2023 | -14.44% |
| Jun 30, 2023 | -32.32% |
| Mar 31, 2023 | -14.19% |
| Dec 31, 2022 | 27.49% |
| Sep 30, 2022 | -9.60% |
| Jun 30, 2022 | -113.15% |
| Mar 31, 2022 | 43.32% |
| Dec 31, 2021 | -19.46% |
| Sep 30, 2021 | -3.28% |